Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Boger

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Bioorganic & Medicinal Chemistry|July 6, 2000
Conformationally restricted analogues designed for selective inhibition of GAR Tfase versus thymidylate synthase or dihydrofolate reductaseD L Boger, M A Labroli, T H Marsilje, et al.
Bioorganic & Medicinal Chemistry|July 29, 1998
Design, synthesis, and evaluation of potential GAR and AICAR transformylase inhibitorsD L Boger, M J Kochanny, H Cai, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 9, 2009
Blockade of endocannabinoid-degrading enzymes attenuates neuropathic painS G Kinsey, J Z Long, S T O'Neal, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2000
Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamideD L Boger, H Sato, A E Lerner, et al.
Biochemistry|March 17, 1999
N-acylglycine amidation: implications for the biosynthesis of fatty acid primary amidesB J Wilcox, K J Ritenour-Rodgers, A S Asser, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Bioorganic & Medicinal Chemistry|July 6, 2000
Conformationally restricted analogues designed for selective inhibition of GAR Tfase versus thymidylate synthase or dihydrofolate reductaseD L Boger, M A Labroli, T H Marsilje, et al.
Bioorganic & Medicinal Chemistry|July 29, 1998
Design, synthesis, and evaluation of potential GAR and AICAR transformylase inhibitorsD L Boger, M J Kochanny, H Cai, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 9, 2009
Blockade of endocannabinoid-degrading enzymes attenuates neuropathic painS G Kinsey, J Z Long, S T O'Neal, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2000
Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamideD L Boger, H Sato, A E Lerner, et al.
Biochemistry|March 17, 1999
N-acylglycine amidation: implications for the biosynthesis of fatty acid primary amidesB J Wilcox, K J Ritenour-Rodgers, A S Asser, et al.
Pageof 9